| Authors: |
Kohli MA; Michele A. Kohli (michele.kohli@optum.com) is a director of health economics and outcomes research at Optum in Burlington, Ontario., Farkouh RA; Raymond A. Farkouh is senior director of outcomes research at Pfizer Vaccines Inc., in Collegeville, Pennsylvania., Maschio MJ; Michael J. Maschio is a lead analyst for health economics and outcomes research at Optum in Ontario., McGarry LJ; Lisa J. McGarry is a director of health economics and outcomes research at Ariad Pharmaceuticals Inc., in Cambridge, Massachusetts. At the time of this study, she was a director of health economics and outcomes research at Optum in Boston, Massachusetts., Strutton DR; David R. Strutton is a vice president of outcomes research at Merck in North Wales, Pennsylvania. At the time of this study, he was a vice president of global health and value at Pfizer Inc., Weinstein MC; Milton C. Weinstein is the Henry J. Kaiser Professor of Health Policy and Management at the Harvard T.H. Chan School of Public Health, in Boston. |
